Home Healthcare Pharmaceuticals Antihistamine Drugs Market

Antihistamine Drugs Market Size, Share & Trends Analysis Report By Type (Prescription-based, Over-the-counter (OTC)), By Indication (Urticaria, Allergy, Dermatitis, Others), By Dosage form (Tablets, Capsules, Others), By Route of Administration (Oral, Parenteral, Others), By End-User (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Antihistamine Drugs Market Size

The global antihistamine drugs market size was valued at USD 607.73 million in 2025 and is projected to grow from USD 656.96 million in 2026 to USD 1225.02 million by 2034, registering a CAGR of 8.1% during the forecast period from 2026 to 2034. Asia Pacific dominated the antihistamine drugs market with a market share of 36% in 2025.

The rising prevalence of allergic conditions, such as hay fever and food allergies and the growing awareness and healthcare access are the key factors driving the market demand.

Antihistamines, also known as histamine receptor antagonists, are a class of drugs that inhibit the action of histamine, a naturally occurring substance produced by the body during allergic reactions. By inhibiting histamine's effects on the body's tissues, these medications are commonly used to relieve allergy symptoms such as sneezing, itchiness, a runny nose, and hives. They are available in various forms, including oral tablets, liquids, and topical creams, and reduce the histamine-induced inflammatory response to mitigate allergic symptoms.

There are two major classes of antihistamine medications: first-generation and second-generation antihistamines. First-generation antihistamines, such as diphenhydramine (commonly known as Benadryl) and chlorpheniramine (marketed as Chlor-Trimeton), are commonly employed for the temporary relief of allergy symptoms and are known to have soothing effects. Antihistamines of the second generation, such as loratadine (Claritin), cetirizine (Zyrtec), and fexofenadine (Allegra), are less likely to induce lethargy and are suitable for long-term use.

Antihistamine Drugs Market Size

Download a Free Sample To learn more about this report.

Type Insights

The market is segmented into prescription-based and over-the-counter (OTC). The over-the-counter (OTC) segment is the highest contributor to the market and is expected to grow significantly over the forecast period. Over-the-counter (OTC) antihistamines are available without a prescription and can be purchased directly from pharmacies or retail stores by consumers. These products are intended for self-treating common allergy symptoms, including sneezing, runny nostrils, and itching.

Prescription-based antihistamine drugs segment contains antihistamine medications that require a prescription from a healthcare provider. Antihistamines that require a prescription are typically prescribed for more severe allergic conditions or when a higher level of medical supervision is required. They may also be prescribed to treat symptoms or underlying medical conditions.

Antihistamine Drugs Market Size By Segments

Request Customizationto receive a tailored report.

Indication Insights

The market is segmented into urticaria, allergy, dermatitis, and others. The allergy segment dominates the global market and is expected to grow significantly over the forecast period. The allergy segment includes antihistamine medications prescribed for various allergic conditions, such as hay fever (allergic rhinitis), seasonal allergies, and environmental allergies triggered by pollen, dust mites, or pet dander. Antihistamines are used to treat symptoms including sneezing, a runny nose, and irritated eyes.

The urticaria segment describes antihistamine medications used to treat urticaria, a skin condition typified by the sudden appearance of red, raised, and itchy welts. Antihistamines are frequently prescribed to alleviate hives' irritation and reduce their severity.

Antihistamines are also used to treat dermatitis, which includes inflammatory skin conditions such as atopic dermatitis (eczema) and contact dermatitis. They reduce the itching and inflammation of the epidermis caused by these conditions.

Dosage Form Insights

The market is fragmented into tablets, capsules, and others. The tablets segment owns the highest market share and is expected to grow substantially over the forecast period. Tablets are one of the most common and extensively utilized dosage forms for antihistamines. They are suitable for oral administration and provide accurate dosing. Tablets are also frequently available in numerous strengths and formulations to meet the varying needs of patients.

Capsules are an additional oral dosage form for antihistamine medications. They may contain powdered or liquid medication encased in gelatin or a vegetable shell. Capsules can provide distinct advantages for particular formulations, including expedited disintegration and absorption.

Route of Administration Insights

The market is fragmented into oral, parenteral, and other. The oral segment dominates the global market share and is expected to grow substantially over the forecast period. The oral route of administration entails taking antihistamines by mouth, typically as tablets, capsules, or syrups. Oral administration is one of the most prevalent and convenient self-administration methods.

Parenteral administration involves injecting antihistamines directly into the body without traveling through the digestive system. Injections may be administered intravenously (IV), intramuscularly (IM), or subcutaneously (SC) via this route.

End-Users Insights

The market is fragmented into hospitals, specialty clinics, home care, and others. The homecare segment owns the highest market share and is expected to grow substantially over the forecast period. Homecare encompasses patients who are prescribed antihistamines for self-administration at home. This segment consists of individuals with mild to moderate allergic conditions who are able to control their symptoms with over-the-counter (OTC) antihistamines or prescription medications.

Distribution Channels Insights

The market is fragmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. The retail pharmacy segment is the highest contributor to the market and is expected to grow substantially over the forecast period. Antihistamine medications are frequently distributed through retail pharmacies. For self-administration, patients can purchase prescription-based and over-the-counter (OTC) antihistamines from retail pharmacies.

Antihistamine Drugs Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

Asia-Pacific is the most significant global market shareholder and is predicted to expand substantially over the forecast period. This is due to the rising prevalence of allergic diseases, such as allergic rhinitis, asthma, urticaria, and eczema, in countries such as China, India, Japan, and South Korea. For instance, according to the Hindwai Journal, in China, allergic rhinitis was 27.8% and asthma was 10.2% in 2022. Similarly, according to the article published in Frontiers, in India, allergic rhinitis was 24.4% and asthma was 21.6% in 2022. Moreover, the rising investments and innovations by major players in the antihistamine drug market, such as Bayer AG, Sanofi, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., and GlaxoSmithKline plc, to expand their presence and product portfolio in the region is a key factor boosting the sale of the antihistamine drugs market in Asia-Pacific region.

Asia Pacific Antihistamine Drugs Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

North America Antihistamine Drugs Market Trends

North America is predicted to expand substantially over the forecast period. This is due to the rising prevalence of allergic conditions in North America, such as seasonal allergies, dietary allergies, and environmental allergies. The prevalence of allergies in the region is anticipated to increase the demand for antihistamines. Similarly, the region typically has a well-developed healthcare infrastructure and high consumer knowledge regarding allergy management and treatment options. This awareness is expected to result in increased use of antihistamine medications. Hence, these factors collectively affect North America's antihistamine drugs market growth over the forecast period.

List of Key and Emerging Players in Antihistamine Drugs Market

Akorn Incorporated
Pfizer Inc
GSK plc
Novartis AG
Teva Pharmaceutical Industries Ltd
Boehringer Ingelheim International GmbH
AstraZeneca
Johnson & Johnson Private Limited
Bayer AG
Merck & Co. Inc.

Key Industry Developments

September 2025
Novartis received U.S. FDA approval for remibrutinib, a first-in-class oral Bruton's tyrosine kinase (BTK) inhibitor, for adults with chronic spontaneous urticaria (CSU) who remain symptomatic despite H1-antihistamine treatment. The approval introduced a novel targeted oral treatment option that complements conventional antihistamine therapy for difficult-to-treat patients.

May 2025
Glenmark Specialty received approval from China’s National Medical Products Administration (NMPA) for Ryaltris® (olopatadine hydrochloride and mometasone furoate nasal spray) for the treatment of allergic rhinitis in adults and children. Under its existing licensing agreement, Grand Pharmaceutical Group will commercialize the product in China, expanding access to combination antihistamine therapy in one of the world's largest allergy treatment markets.

Report Scope

Segmentation

By Type 2
  • Prescription-based
  • Over-the-counter (OTC)
By Indication 4
  • Urticaria
  • Allergy
  • Dermatitis
  • Others
By Dosage form 3
  • Tablets
  • Capsules
  • Others
By Route of Administration 3
  • Oral
  • Parenteral
  • Others
By End-User 4
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others
By Distribution Channel 4
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 8
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Singapore
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Akorn Incorporated · Pfizer Inc · GSK plc · Novartis AG · Teva Pharmaceutical Industries Ltd
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The antihistamine drugs market size is valued at USD 656.96 Million in 2026 and is projected to reach USD 1225.02 Million by 2034, at a CAGR of 8.1% during the forecast period 2026-2034.

Asia Pacific dominated the market with a share of 36% in 2025.

The leading players in this market are Akorn Incorporated, Pfizer Inc, GSK plc, Novartis AG, Teva Pharmaceutical Industries Ltd.

The antihistamine drugs market is projected to grow at a CAGR of 8.1% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: